Heart attack diagnosis is associated with intensive care of patients battling with life threatening conditions, which requires sophisticated invasive monitoring devices and life support systems. Heart attack (myocardial infarction) occurs due to reduced or total cut off of oxygenated blood supply to the heart muscle. It is one of the major causes of death observed worldwide and needs to be diagnosed rapidly and accurately. According to Centers for Diseases Control and Prevention, about 735,000 Americans suffer from heart attack every year. Occurrence of heart attacks is increasing in adults as well as in geriatric population across the globe due to unhealthy lifestyle habits, high cholesterol levels, high BMI, and growth in tobacco and alcohol consumption. The demand for heart attack diagnostic devices has increased owing to rise in need for continuous monitoring of individuals, accessibility for patient, changing lifestyle, higher investments in R&D, and technological advancement. Further, various international organizations and government across the globe are creating awareness about monitoring devices among the population.
Read the Comprehensive Overview of Heart Attack Diagnostics Market: http://www.transparencymarketresearch.com/heart-attack-diagnostics-market.html
Several factors are responsible to propel the heart attack diagnostics market, but few factors are likely to continue to restrain the growth of the market in the near future such as the low Medicare reimbursements provided for the peripatetic cardiac outpatient telemetry electrocardiogram (ECG).
The heart attack diagnostics market can be segmented on the basis of test, end-user, and geography. In terms of test, the market can be divided into electrocardiogram (ECG), blood test, chest X-ray, echocardiogram, coronary catheterization (angiogram), exercise stress test, and magnetic resonance imaging (MRI). Among these, ECG has a wider application and contributes to tremendous growth of the market. End-user of this market includes hospitals, specialty clinics, and pathology among others.
In terms of geography, the heart attack diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In terms of market revenue, North America is estimated to dominate the global heart attack diagnostics market owing to increased adoption of technologically advanced diagnostic equipment. The Asia Pacific market is projected to grow at a higher rate owing to high incidence of heart attacks and soaring death rates due to heart diseases.
The heart attack diagnostics market is highly fragmented due to involvement of many recognized as well as emerging players in this market. Key players involved in the heart attack diagnostics market include Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories Inc., Siemens Healthcare Diagnostics, GE Healthcare, Life Sign LLC, Hitachi Medical Systems, and Schiller AG.
Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=17996
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
Email: [email protected]